Vivesto AB (Sweden) Today
| VIVE Stock | 0.22 0.01 4.35% |
Performance0 of 100
| Odds Of DistressOver 68
|
Vivesto AB is selling for under 0.22 as of the 31st of January 2025; that is 4.35 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.22. Vivesto AB has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 31st of January 2025. Click here to learn more.
Moving together with Vivesto Stock
Moving against Vivesto Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Vivesto Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Vivesto AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Vivesto AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
Vivesto AB (VIVE) is traded on Stockholm Exchange in Sweden and employs 17 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 222.91 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vivesto AB's market, we take the total number of its shares issued and multiply it by Vivesto AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Vivesto AB operates under Healthcare sector and is part of Drug Manufacturers-Specialty & Generic industry. The entity has 538.04 M outstanding shares.
Vivesto AB generates negative cash flow from operations
Check Vivesto AB Probability Of Bankruptcy
Ownership AllocationVivesto AB shows a total of 538.04 Million outstanding shares. Vivesto AB maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Vivesto Ownership Details
Vivesto AB Risk Profiles
Although Vivesto AB's alpha and beta are two of the key measurements used to evaluate Vivesto AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.45 | |||
| Standard Deviation | 3.36 | |||
| Variance | 11.27 | |||
| Risk Adjusted Performance | (0.04) |
Vivesto Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vivesto AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Vivesto AB Corporate Management
Elected by the shareholders, the Vivesto AB's board of directors comprises two types of representatives: Vivesto AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vivesto. The board's role is to monitor Vivesto AB's management team and ensure that shareholders' interests are well served. Vivesto AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vivesto AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kai Wilkinson | Chief Officer | Profile | |
| Urban Ekelund | IR Mang | Profile | |
| Henrik Rnnberg | Chief Health | Profile | |
| John Cosby | Head Affairs | Profile | |
| Robert Maiorana | Head CFO | Profile | |
| Dzianis Babrou | Head Devel | Profile | |
| Christer MD | Acting Officer | Profile |
Additional Tools for Vivesto Stock Analysis
When running Vivesto AB's price analysis, check to measure Vivesto AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivesto AB is operating at the current time. Most of Vivesto AB's value examination focuses on studying past and present price action to predict the probability of Vivesto AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivesto AB's price. Additionally, you may evaluate how the addition of Vivesto AB to your portfolios can decrease your overall portfolio volatility.